The latest on artificial intelligence transforming medicine

Clairity Breast’s NCCN Inclusion Highlights the Growing Power of AI Risk Stratification

Clairity Breast was added to NCCN guidance for breast cancer screening and diagnosis, a meaningful milestone for an AI product trying to become part of standard care. The development suggests guideline bodies are increasingly open to AI when it supports better risk-based screening. The move also illustrates how quickly breast imaging AI is transitioning from innovation story to clinical infrastructure story.